- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07654699
Active and Mindful - A Mind-Body Programme for People With Multiple Sclerosis: a Feasibility Study Protocol
The purpose of this exploratory study is to evaluate the feasibility and acceptability of the "Active and Mindful" home-based mind-body exercise program for individuals diagnosed with Multiple Sclerosis (MS) in Portugal and Spain.
Multiple Sclerosis often leads to physical and psychological challenges that impact health-related quality of life. Mind-body exercise programs combined with remote supervision present an accessible, flexible alternative to traditional center-based rehabilitation. This study assesses the practicality of implementing a 9-month online intervention delivered via video-conferencing, focusing on recruitment rates, retention, participant attendance, and overall satisfaction. Secondarily, the study explores pre-to-post changes in clinical and psychological indicators such as perceived physical exertion and health-related quality of life.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Background:
Multiple Sclerosis (MS) is a chronic, progressive neurological condition that requires ongoing management to maintain physical functioning and psychological well-being. Exercising at home using digital health solutions offers a viable pathway to increase adherence and overcome logistical barriers (such as transportation or geographic isolation) often faced by clinical populations. This exploratory study investigates the "Active and Mindful" program, a remotely supervised, home-based intervention designed specifically to accommodate the functional variations of people living with MS.
Objectives:
- To determine the feasibility of the program through quantitative benchmarks, specifically recruitment efficiency, attrition (retention rate), and global session attendance.
- To evaluate participant acceptability and satisfaction with the synchronous group dynamic.
- To collect preliminary exploratory data on patient-reported outcomes, including perceived exertion during sessions and health-related quality of life domains.
Methodology:
The study utilized a non-randomized, single-group, interventional design spanning a total duration of 9 months. Individuals with MS were recruited via digital interest forms and institutional channels across Portugal (in collaboration with the Sociedade Portuguesa de Esclerose Múltipla - SPEM) and Spain (in collaboration with the Asociación de Familiares y Afectados de Esclerosis Multiple - AFAEM).
The intervention was structured into distinct functional tiers to ensure physical safety and progressive adaptation:
- Synchronous Phase: Live, exercise sessions conducted via the ZOOM platform in small groups ranging from 3 to 8 participants, organized according to their baseline functional capacity. Sessions were held twice a week and incorporated physical fitness, adapted Pilates, Tai-Chi, mindfulness protocols, and guided relaxation techniques.
- Asynchronous Phase: During the latter half of the program, participants were progressively introduced to and integrated with digital video resources hosted on a dedicated web platform, promoting independent home practice.
- Session Monitoring: To assess the specific feasibility of these pre-recorded video sessions, participants completed study-specific session evaluation forms.
Data collection and Timeline:
Quantitative data and validated health surveys were administered at three distinct time points to capture the progression of the cohort:
- Baseline(T0): Collected before the first exercise session to record sociodemographic characteristics, clinical history, and initial status.
- Midpoint Assessment (T1): Conducted at approximately 4.5 months to monitor early compliance and initial shifts in perceived effort.
- Post-test (T2): Completed at month 9 to evaluate the terminal outcomes, overall compliance, retention metrics, and final system satisfaction.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Evora, Portugal, 7000-727
- Departamento de Desporto e Saúde, Escola de Saúde e Desenvolvimento Humano, Universidade de Évora
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Adult patients diagnosed with Multiple Sclerosis living in Portugal or Spain;
- Expanded Disability Status Scale (EDSS) score below 8;
- First to register on the online inscription survey (subject to limited spots)
- Time availability to comply with the session schedules;
- Access to compatible digital devices with visual feedback (Camera) and reliable internet connectivity;
- Ability to install and use the ZOOM platform with the camera turned on.
Exclusion Criteria:
- Significant medical comorbidities that impact or prevent safe exercise participation;
- Pregnant women.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Active and Mindful Mind-Body Exercise Group
People with Multiple Sclerosis participating in a remotely supervised, home-based mind-body exercise program
|
An online exercise program (combining synchronous and asynchronous sessions) conducted in a small groups (3 to 8 participants) tailored to functional levels.
Sessions were held twice a week for 9months, including physical fitness, Pilates, Tai-Chi, mindfulness, and relaxation techniques.
In the final phase, asynchronous video resources on a web platform were introduced
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Recruitment Rate
Tidsram: Baseline (T0)
|
Percentage of participants recruited out of the total expressions of interest received.
|
Baseline (T0)
|
|
Retention Rate
Tidsram: Post-intervention (T2 - 9 months)
|
Percentage of participants who completed the intervention and the final follow-up assessments
|
Post-intervention (T2 - 9 months)
|
|
Global Attendance Rate
Tidsram: Through the 9 month intervention
|
Mean percentage of exercise sessions attended by the participants throughout the program.
|
Through the 9 month intervention
|
|
Program Satisfaction and Acceptability
Tidsram: At the end of every training session throughout the 9-month intervention period.
|
Participant satisfaction scores measured through a feedback questionnaire (scored on a 1 to 5 Likert scale, where higher scores indicate higher satisfaction).
|
At the end of every training session throughout the 9-month intervention period.
|
|
Perceived Exertion (Borg RPE)
Tidsram: At the end of every training session throughout the 9-month intervention period.
|
Assessment of physical effort intensity during exercise sessions using the Borg Rating of Perceived Exertion (RPE) scale 0-10.
Higher scores indicate higher physical exertion.
|
At the end of every training session throughout the 9-month intervention period.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
General Health-Related Quality of Life (SF-36)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Generic health status questionnaire covering 8 domains.
Subscale scores range from 0 to 100, where higher scores indicate better health status and quality of life.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Multiple Sclerosis-Specific Quality of Life (MSQOL-54)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Evaluation of MS-specific quality of life across physical and mental health composites.
Scores range from 0 to 100, where higher scores represent superior quality of life.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Modified Fatigue Impact Scale (MFIS)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Assessment of the impact of fatigue on physical, cognitive, and psychosocial functioning using the Modified Fatigue Impact Scale (MFIS).
Total score ranges from 0 to 84, where higher scores indicate a greater negative impact of fatigue.
Scores above 38 indicate significant clinical fatigue.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Activities-Specific Balance Confidence (ABC)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Self-reported scale measuring a patient's confidence in maintaining balance during various daily ambulatory activities.
Scores range from 0% to 100%, where higher percentages indicate greater balance confidence.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Mindfulness Attention Awareness Scale (MAAS)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Assessment of mindful presence and awareness in daily life using the Mindful Attention Awareness Scale (MAAS).
Total score ranges from 1 to 6 (calculated as a mean of items), where higher scores indicate higher dispositional mindfulness.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Interoceptive Awareness (MAIA)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Evaluation of body awareness and connection through the Multidimensional Assessment of Interoceptive Awareness (MAIA).
It measures 8 subscales scored from 0 to 5, with higher scores indicating better interoceptive awareness and body trusting.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Physical Activity Levels (IPAQ)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Assessment of total physical activity over the previous 7 days using the International Physical Activity Questionnaire (IPAQ).
Outcomes are reported as continuous scores in MET-minutes/week or categorized into Low, Moderate, or High activity groups.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Pain Severity and Interference (BPI)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Evaluation of pain intensity and its impact on daily functional activities using the Brief Pain Inventory (BPI).
It generates two major subscales: Pain Severity (0-10) and Pain Interference (0-10), where higher scores denote worse pain and higher functional impairment.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Hospital Anxiety and Depression Scale (HADS)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Evaluation of psychological distress using the Hospital Anxiety and Depression Scale (HADS), comprising two subscales: Anxiety (HADS-A) and Depression (HADS-D).
Each subscale scores from 0 to 21, where higher scores indicate greater severity of symptoms (worse outcome).
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
State Mindfulness Scale (SMS)
Tidsram: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Measurement of state mindfulness experienced during or immediately after intervention sessions using the State Mindfulness Scale.
The SMS is a 21-item self-report measure with a 5-point Likert-type scale (1 = not at all to 5 = very well), comprising two subscales: State Mindfulness of Mind (15 items) and State Mindfulness of Body (6 items).
Total scores range from 21 to 105, where higher scores reflect greater state mindfulness (better outcome).
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Samarbetspartners och utredare
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Sjukdomar i nervsystemet
- Autoimmuna sjukdomar
- Immunsystemets sjukdomar
- Demyeliniserande autoimmuna sjukdomar, CNS
- Autoimmuna sjukdomar i nervsystemet
- Demyeliniserande sjukdomar
- Multipel skleros
- Motorisk aktivitet
- Rörelse
- Muskuloskeletala fysiologiska fenomen
- Muskuloskeletala och neurala fysiologiska fenomen
- Utöva
Andra studie-ID-nummer
- 101134389
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .